Infant Journal
Browse articlesMaintaining quality of care through a pandemic and setting goals for future improvement
The National Neonatal Audit Programme (NNAP) was established in 2006 and continues to play an important role in driving and supporting improvements in neonatal care. The past two years have been a period of change for the NNAP, bringing a new data flow methodology, exciting opportunities to further develop the NNAP, and a new contract for the Royal College of Paediatrics and Child Health (RCPCH) to deliver the audit until 2025.
Sam Oddie
NNAP Clinical Lead, Consultant
Neonatologist, Bradford Teaching Hospitals
NHS FT
Rachel Winch
NNAP Manager, Royal College of Paediatrics
and Child Health
nnap@rcpch.ac.uk
Full text available by subscription ...
Subscribe
The full text of this article is available to subscribers in text, and in Tablet/iPad format and as a PDF file.
Please subscribe and log in to see the full article.
Keywords
late preterm; early term; respiratory distress; surfactant
Key points
- Late preterm and early term babies are a large and under-researched group.
- Management of respiratory distress in mature infants born before full term varies widely.
- The SurfON Study is a large multicentre randomised controlled trial of early surfactant compared with expectant management in babies born at 34-38 weeks of gestation with respiratory distress.
Also published in Infant:
VOLUME 14/ISSUE 6, NOVEMBER 2018
Surfactant replacement therapy for newborn infants with respiratory distress syndrome (RDS) has been available for about 35 years. During this time practice has evolved in relation to type of surfactant, timing and mode of administration. This review looks briefly at the history of surfactant use and how this has changed to shape current practice. We also speculate on potential future innovations that may further refine how this life-saving therapy is used.
